Glenview Capital Management — ELV Trade History

Quarter-by-quarter changes in the ELEVANCE HEALTH INC FORMERLY position · CUSIP 036752103
Currently held · 1 QFirst seen: 2016 Q3
QuarterFiledActivitySharesΔ SharesΔ %Value% Port.
2026 Q22026-08-14New66,59966,599$25.8M0.47%
2026 Q12026-05-15
2025 Q42026-02-17
2025 Q32025-11-14
2025 Q22025-08-14
2025 Q12025-05-15
2024 Q42025-02-14
2024 Q32024-11-14Sold out-98,578-100.0%
2024 Q22024-08-14Reduce98,578-75,651-43.4%$53.4M1.05%
2024 Q12024-05-15Add174,229136,320+359.6%$90.3M1.58%
2023 Q42024-02-14Add37,90922,982+154.0%$17.9M0.38%
2023 Q32023-11-14New14,92714,927$6.5M0.15%
2023 Q22023-08-14Sold out-11,867-100.0%
2023 Q12023-05-15New11,86711,867$5.5M0.12%
2022 Q42023-02-14
2022 Q32022-11-14
2022 Q22022-08-11
2022 Q12022-05-16Sold out-172,713-100.0%
2021 Q22022-02-18New172,713172,713$65.9M1.09%
2021 Q32022-02-18
2021 Q42022-02-14Sold out-263,633-100.0%
2021 Q12021-05-17Add263,63379,172+42.9%$94.6M1.60%
2020 Q42021-02-16New184,461184,461$59.2M1.36%
2020 Q32020-11-16
2020 Q22020-08-14
2020 Q12020-05-15Sold out-751,142-100.0%
2019 Q42020-02-14Reduce751,142-116,885-13.5%$226.9M1.99%
2019 Q32019-11-14Reduce868,027-2,790-0.3%$208.4M2.19%
2019 Q22019-08-14Reduce870,817-147,420-14.5%$245.8M2.23%
2019 Q12019-05-15Add1,018,237145,804+16.7%$292.2M2.61%
2018 Q42019-02-14Reduce872,433-414,516-32.2%$229.1M2.22%
2018 Q32018-11-14Add1,286,94911,287+0.9%$352.7M2.24%
2018 Q22018-08-14Reduce1,275,662-1,005,673-44.1%$303.6M2.07%
2018 Q12018-05-15Reduce2,281,335-776,162-25.4%$501.2M2.93%
2017 Q42018-02-14Reduce3,057,497-745,018-19.6%$688.0M3.72%
2017 Q32017-11-14Reduce3,802,515-248,116-6.1%$722.0M4.19%
2017 Q22017-08-14Reduce4,050,631-661,014-14.0%$762.0M4.94%
2017 Q12017-05-15Reduce4,711,645-1,162,404-19.8%$779.2M5.17%
2016 Q42017-02-14Add5,874,049276,807+4.9%$844.5M5.71%
2016 Q32016-11-14New5,597,2425,597,242$701.4M5.02%

Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.